Physician profile
Bailey Bergman
NPI 1447851639
$1,738.81
in general payments reported to CMS, 2019-2025
10 companies · $800 in 2025
The $800 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.85 · 2022: $11.44 · 2023: $14.98 · 2024: $835 · 2025: $800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,650.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $882.48 | 2024-2025 | Dovato, Cabenuva, Apretude |
| Merck Sharp & Dohme LLC | $360.33 | 2024-2025 | Pifeltro, Zerbaxa, Delstrigo |
| Paratek Pharmaceuticals, INC. | $123.97 | 2024-2025 | Nuzyra |
| Abbvie INC. | $103.04 | 2024-2025 | |
| Insmed, INC. | $98.76 | 2025 | Arikayce |
| Organon LLC | $88.29 | 2021-2022 | |
| Melinta Therapeutics, LLC | $34.12 | 2024-2025 | Kimyrsa, Rezzayo |
| Astellas Pharma US INC | $16.48 | 2024 | Cresemba |
| Cumberland Pharmaceuticals, INC. | $16.36 | 2024 | Vibativ |
| Mylan Specialty L.P. | $14.98 | 2023 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bailey Bergman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.